News

ALIPANC researchers organized the Symposium “Pancreatic Cancer: challenges and future perspectives”.

by | September 26, 2025 | Uncategorized | 0 Comments

On September 17, at the Ramón Areces Foundation headquarters, Mariano Barbacid and Carmen Guerra, researchers at the Spanish National Cancer Research Center (CNIO), successfully organized the Symposium "Pancreatic Cancer: Challenges and Future Prospects". The meeting...
Read more

Announcement: Botton-Champalimaud International Pancreatic Cancer Conference 2025

by | September 19, 2025 | Sin categorizar | 0 Comments

The second edition of the Botton-Champalimaud International Pancreatic Cancer Conference (BCIPCC) will take place from October 29th to November 1st, 2025, at the Botton-Champalimaud Pancreatic Cancer Centre in Lisbon. Following the success of the inaugural 2024...
Read more

Next week: Conference “Pancreatic Cancer: Challenges and future perspectives” in Madrid

by | September 11, 2025 | Sin categorizar | 0 Comments

On September 17th, the conference "Pancreatic Cancer: challenges and future perspectives" will take place at the Ramón Areces Foundation. Leading international experts, including members of ALIPANC, will present advances in basic, translational and clinical research....
Read more

Tumor Treating Fields with Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-label, pivotal phase III PANOVA-trial. Babiker et al.

by | July 29, 2025 | Sin categorizar | 0 Comments

  At the 2025 ASCO congress it was presented the positive results of the PANOVA-3 trial. This is the first and the only positive trial in locally advanced pancreatic cancer (LA-PDAC) Tumor treating fields (TTFields) use alternating electric fields to disrupt...
Read more

Meeting of ALIPANC researchers at the CNIO on the occasion of Dr. Peter Bailey’s visit.

by | July 28, 2025 | Sin categorizar | 0 Comments

Last Thursday, Dr. Peter Bailey, Director of Translational Genomics at the Botton-Champalimaud Center in Lisbon and member of ALIPANC, visited the Spanish National Cancer Research Center (CNIO), where he gave a seminar focused on the role of extrachromosomal DNA...
Read more

Symposium “Pancreatic Cancer: Challenges and Future Perspectives”: September 17, 2025

by | July 15, 2025 | Sin categorizar | 0 Comments

This one-day symposium, divided into four sessions, will bring together experts in basic, translational and clinical research working on the study of pancreatic cancer, one of the most aggressive and best characterized tumors at the molecular level. Key aspects of...
Read more

ALIPANC Researchers Identify a New Genetic Mechanism That Increases Pancreatic Cancer Risk

by | July 11, 2025 | Sin categorizar | 0 Comments

A study led by scientists from two ALIPANC groups at the Spanish National Cancer Research Centre (CNIO) has uncovered the mechanism by which a genetic variant acts and possibly increases the risk of developing pancreatic cancer. The findings have been published in the...
Read more

Course announcement: “From biological fundamentals to emerging therapies: a complete immersion in pancreatic cancer”.

by | June 2, 2025 | Sin categorizar | 0 Comments

ALIPANC invites you to this course: “From biological fundamentals to emerging therapies: a complete immersion in pancreatic cancer.” Date: from June 25th to 27th Venue: Faculty of Experimental Sciences (Facultad de Ciencias Experimentales) - Universidad Francisco de...
Read more

ALIPANC researchers discover ELOVL6, a new therapeutic target to boost chemotherapy in pancreatic cancer

by | May 5, 2025 | Sin categorizar | 0 Comments

Joint research by the Hospital 12 de Octubre and the Universidad Francisco de Vitoria has identified a new therapeutic target in pancreatic cancer: the enzyme ELOVLL6. The inhibition or silencing of this enzyme modifies the rigidity and permeability of the cell...
Read more

ALIPANC scientists identify one of the keys to stromal activation in pancreatic cancer

by | April 16, 2025 | Sin categorizar | 0 Comments

This study published in PNAS has identified a previously unknown function of the protein Galectin-1 within the fibroblast nucleus, where it plays a key role in the control of gene expression through epigenetic mechanism.

Read more